Michael Augsberger is the Chief Financial Officer of Lumendi Ltd.
His experience includes 25 years in the clinical research, corporate development, private equity and investment banking industries.
Mr. Augsberger began his career in the CRO industry with IBAH, Inc. There he focused on regulatory affairs and business development.
He was instrumental in establishing the firm’s international division, driving corporate development efforts globally, and supporting the firm’s eventual IPO and sale.
Mr. Augsberger also spent more than 12 years within the global healthcare investment banking teams at Deutsche Bank and UBS, where he played significant roles in M&A and financing transactions worth over $50 billion.
Most recently, Mr. Augsberger served as Managing Director, Europe, for Fosun International, where he originated and executed a number of the firm’s investments in the US and European healthcare sectors.
Mr. Augsberger obtained a Bachelor of Arts in Economics from Bucknell University and an MBA from the Rotterdam School of Management, Erasmus University.